TMO Financial Facts
Operating Income: 315MTotal costs and operating expenses: 2.66B
See Full Income Statement
Raw materials: 363.7M
Property, Plant and Equipment, at Cost: 2.59B
See Full Balance Sheet
Thermo Fisher Scientific, Inc. (TMO) Earnings
|
Expand Research on TMO
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/27/22 | Q222 | N/A | $5.00 | N/A | N/A | $9.97B | N/A | N/A | N/A | ||
| 4/28/22 | Q122 | $7.25 | $6.18 | +$1.07 | $11.82B | $10.63B | N/A | ![]() | ![]() | Details | |
| 2/2/22 | Q421 | $6.54 | $4.93 | +$1.61 | $10.7B | $8.84B | N/A | ![]() | ![]() | Details | |
| 10/27/21 | Q321 | $5.76 | $4.67 | +$1.09 | $9.33B | $8.39B | N/A | ![]() | ![]() | Details | |
| 7/28/21 | Q221 | $5.60 | $5.49 | +$0.11 | $9.27B | $8.77B | N/A | ![]() | ![]() | Details | |
| 4/29/21 | Q121 | $7.21 | $6.65 | +$0.56 | $9.91B | $9.72B | N/A | ![]() | ![]() | Details | |
| 2/1/21 | Q420 | $7.09 | $6.29 | +$0.80 | $10.55B | $9.3B | N/A | ![]() | ![]() | Details | |
| 10/21/20 | Q320 | $5.63 | $4.31 | +$1.32 | $8.52B | $7.65B | N/A | ![]() | ![]() | Details |

